Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Ogihara

Showing results (111-120 of 337) with videos related to

Pageof 34
Sort By:
Metabolism: Clinical and Experimental|May 7, 2005
Functional polymorphism in Z-DNA-forming motif of promoter of SLC11A1 gene and type 1 diabetes in Japanese subjects: association study and meta-analysisMasanori Nishino, Hiroshi Ikegami, Tomomi Fujisawa, et al.
Atherosclerosis|May 17, 2008
Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migrationSuguru Shiraya, Takashi Miyake, Motokuni Aoki, et al.
The American Journal of Cardiology|September 29, 2005
Usefulness of a new grading system based on coronary flow velocity pattern in predicting outcome in patients with acute myocardial infarction having percutaneous coronary interventionAtsunori Okamura, Hiroshi Ito, Katsuomi Iwakura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 23, 2011
Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients. - Primary and secondary prevention of ischemic heart disease in a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial-Kenji Ueshima, Koji Oba, Shinji Yasuno, et al.
Journal of the American College of Cardiology|January 18, 2005
Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection deviceAtsunori Okamura, Hiroshi Ito, Katsuomi Iwakura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 25, 2008
Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) studyHiroaki Naritomi, Toshiro Fujita, Sadayoshi Ito, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2007
Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese populationShinsuke Noso, Tomomi Fujisawa, Yumiko Kawabata, et al.
Blood Pressure. Supplement|August 3, 2005
A calcium-channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertensionHirofumi Makino, Motokuni Aoki, Naotaka Hashiya, et al.
Journal of Molecular and Cellular Cardiology|July 26, 2005
Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytesHironori Tashiro, Motokuni Aoki, Mitsuaki Isobe, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibilityYoshihisa Hiromine, Hiroshi Ikegami, Tomomi Fujisawa, et al.
Pageof 34

Showing results (111-120 of 337) with videos related to

Sort By:
Pageof 34
Metabolism: Clinical and Experimental|May 7, 2005
Functional polymorphism in Z-DNA-forming motif of promoter of SLC11A1 gene and type 1 diabetes in Japanese subjects: association study and meta-analysisMasanori Nishino, Hiroshi Ikegami, Tomomi Fujisawa, et al.
Atherosclerosis|May 17, 2008
Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migrationSuguru Shiraya, Takashi Miyake, Motokuni Aoki, et al.
The American Journal of Cardiology|September 29, 2005
Usefulness of a new grading system based on coronary flow velocity pattern in predicting outcome in patients with acute myocardial infarction having percutaneous coronary interventionAtsunori Okamura, Hiroshi Ito, Katsuomi Iwakura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 23, 2011
Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients. - Primary and secondary prevention of ischemic heart disease in a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial-Kenji Ueshima, Koji Oba, Shinji Yasuno, et al.
Journal of the American College of Cardiology|January 18, 2005
Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection deviceAtsunori Okamura, Hiroshi Ito, Katsuomi Iwakura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 25, 2008
Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) studyHiroaki Naritomi, Toshiro Fujita, Sadayoshi Ito, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2007
Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese populationShinsuke Noso, Tomomi Fujisawa, Yumiko Kawabata, et al.
Blood Pressure. Supplement|August 3, 2005
A calcium-channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertensionHirofumi Makino, Motokuni Aoki, Naotaka Hashiya, et al.
Journal of Molecular and Cellular Cardiology|July 26, 2005
Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytesHironori Tashiro, Motokuni Aoki, Mitsuaki Isobe, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibilityYoshihisa Hiromine, Hiroshi Ikegami, Tomomi Fujisawa, et al.
Pageof 34